USX:LYRA - Lyra Therapeutics Inc

Lyra Therapeutics Inc
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-264.51K% -	-15.27K% -	-755.89% -	-761.97% -	-3.37K% -	-4.06K% -	-4.57K% -	-4.92K% -	-4.34K% -	-4.02K% -	-4.1K% -	-5.57K% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-264.5K% -	-15.3K% -	-757.43% -	-763.54% -	-3.38K% -	-4.03K% -	-4.63K% -	-4.92K% -	-4.42K% -	-4.21K% -	-4.27K% -	-4.1K% -
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	14K -	285K 1935.7%	5.65M 1883.2%	6.06M 7.2%	1.62M -73.2%	1.36M -16.0%	1.3M -4.3%	1.24M -5.1%	1.42M 14.9%	1.56M 9.5%	1.68M 7.8%	1.82M 8.3%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	67.76M -11.2%	54.87M -19.0%	47.34M -13.7%	130.03M 174.7%	119.46M -8.1%	109.97M -7.9%	93.87M -14.6%	125.67M 33.9%	120.58M -4.1%	142.6M 18.3%	141.53M -0.8%	94.58M -33.2%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	20.57M 9.2%	20.55M -0.1%	19.19M -6.6%	19M -1.0%	26.24M 38.1%	29.21M 11.3%	27.78M -4.9%	27.1M -2.4%	36.34M 34.1%	53.18M 46.4%	64.02M 20.4%	63.6M -0.7%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	47.19M -17.9%	34.32M -27.3%	28.16M -18.0%	111.03M 294.3%	93.22M -16.0%	80.75M -13.4%	66.09M -18.2%	98.58M 49.2%	84.24M -14.5%	89.42M 6.2%	77.5M -13.3%	30.98M -60.0%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-20.39M -	-25.82M -	-30.14M -	-41.99M -	-42.52M -	-43.38M -	-47.33M -	-53.14M -	-56.41M -	-63.3M -	-69.91M -	-75.61M -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	81.88M -5.8%	74.92M -8.5%	66.43M -11.3%	69.38M 4.4%	58.46M -15.7%	46.08M -21.2%	34.08M -26.0%	122.09M 258.2%	110.98M -9.1%	33.94M -69.4%	23.41M -31.0%	55.75M 138.1%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	58.46M -15.7%	46.08M -21.2%	34.08M -26.0%	122.09M 258.2%	110.98M -9.1%	33.94M -69.4%	23.41M -31.0%	55.75M 138.1%	26.24M -52.9%	23.75M -9.5%	17.79M -25.1%	33.9M 90.5%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-23.79M -	-29.2M -	-32.45M -	-43.69M -	-43.74M -	-43.55M -	-47.45M -	-53.31M -	-56.7M -	-64.35M -	-73.06M -	-78.88M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-36.92M -	-43.51M -	-42.72M -	-46.17M -	-54.66M -	-55.28M -	-59.62M -	-60.87M -	-61.76M -	-62.68M -	-68.88M -	-101.39M -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-37.03M -	-43.51M -	-42.72M -	-46.17M -	-54.66M -	-55.28M -	-59.62M -	-60.87M -	-61.76M -	-62.68M -	-68.88M -	-101.39M -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-2.76 -	-3.35 -	-3.29 -	-2.81 -	-2.52 -	-1.83 -	-1.35 -	-1.5 -	-1.4 -	-1.26 -	-1.17 -	-1.56 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-57.82% -	-79.98% -	-89.28% -	-54.79% -	-77.86% -	-96.08% -	-126.52% -	-58.08% -	-69.6% -	-73.67% -	-95.93% -	-156.52% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-47.75% -	-64.13% -	-71.05% -	-44.74% -	-58.39% -	-67.07% -	-84.44% -	-47.61% -	-51.46% -	-49.63% -	-58.52% -	-92.07% -